Portal de Periódicos da CAPES

Differential somatostatin receptor (SSTR) 1–5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors

2015; Elsevier BV; Volume: 417; Linguagem: Inglês

10.1016/j.mce.2015.09.016

1872-8057

Katja Kiseljak‐Vassiliades, Mei Xu, Taylor Mills, Elizabeth Smith, Lori Silveira, Kevin O. Lillehei, Janice M. Kerr, Bette K. Kleinschmidt‐DeMasters, Margaret E. Wierman,

Growth Hormone and Insulin-like Growth Factors

The aim of this study was to examine whether differential expression of somatostatin receptors (SSTR) 1-5 and downstream effectors are different in densely (DG) and sparsely (SG) granulated histological growth hormone (GH) pituitary tumor subtypes.The study included 33 acromegalic patients with 23 DG and 10 SG tumors. SSTR1-5 were measured by qPCR and immunoblotting. Signaling candidates downstream of SSTR2 were also assessed.SSTR2 mRNA and protein levels were significantly higher in DG compared to SG tumors. Downstream of SSTR2, p27(kip1) was decreased (2.6-fold) in SG compared to DG tumors, suggesting a potential mechanism of SSA resistance in SG tumors with intact SSTR2 expression. Re-expression of E-cadherin in GH pituitary cell increased p27(kip1) levels.Histological subtyping correlated with SSTR2, E cadherin and p27(kip) protein levels and these may serve as useful biomarkers in GH tumors to predict behavior and response to therapy with SSA.